Role of Secondary Attack Rate in The Surge of COVID 19 Cases: A Comparative Retrospective Cohort Study between First Wave and Second Wave of COVID 19

Author:

Patel JayendrakumarORCID,Parikh Shalin,Patel Rakesh,Patel Shwetaben,Patel Ronak,Patel Payalben,Patel Ankita

Abstract

India had the worst conditions during the second wave, and yet, the cause of the enormous spike in COVID-19 cases in a short time span remains unexplained. We aimed to decipher the cause of the enormous spike in COVID-19 cases in the second wave in India. A comparative retrospective cohort study was conducted between the first wave and the second wave. An individual primary case was interviewed using the "COVID-19 transmission questionaries sheet" to trace the total number of primary cases and age-wise unrestricted social interaction and secondary cases. Between January-2021 and May-2021, 1587 unrestricted social interactions were traced with 437 primary cases for the second wave. While for the first wave, 436 unrestricted social interactions were traced with 112 primary cases between January-2020 and December-2020. In the second wave, 36.8% of primary cases developed 334 secondary cases, while 25.0% of primary cases developed 82 secondary cases in the first wave. The secondary attack rate rose 2.5-fold in the age group >50years, and rose ~86% in the age group <10years, while it remained stable in the age group 10-50years. The overall 58% increment in secondary attack rate in the second wave indicates changes in the pattern of unrestricted social interaction amongst household members. This was further supported by the incidence proportion rate that surprisingly rose to ~39% in households of two- and three members in the second wave, while it was negligible in the first wave. Changes in the pattern of unrestricted social interaction among household members and a high affinity of the delta variant virus for infecting people in the age groups of <10 years and >50 years escalated the secondary attack rate and incidence proportion rate that led to the unprecedented surge of COVID-19 cases in the second wave.

Publisher

The Journal of Pharmaceutical Sciences and Medicinal Research

Reference14 articles.

1. COVID 19 International update: Global Covid infections pass 173 million. Jun 7, 2021 (last updated), Pharmaceutical Technology. (https://www.pharmaceutical-technology.com/special-focus/covid-19/international-update-global-covid-infections-pass-173-million/)

2. Patel, J., Parikh, S., Patel, S., & Patel, R. (2021). A Comprehensive Overview On The Most Recent Trends In Covid-19 Diagnosis, Treatment Options And Vaccine Development Status: Comprehensive Overview On The Most Recent Trends In Covid-19. The Journal of Pharmaceutical Sciences and Medicinal Research, 1(1), 001-020. DOI: 10.53049/tjopam.2021.v001i01.001

3. Coronavirus disease (COVID-19): How is it transmitted?, April 30, 2021. (https://www.who.int/news-room/q-a-detail/coronavirus-disease-covid-19-how-is-it-transmitted).

4. Considerations in the investigation of cases and clusters of COVID-19: interim guidance, 2 April 2020. Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/considerations-in-the-investigation-of-cases-and-clusters-of-covid-19).

5. Global surveillance for COVID-19 caused by human infection with COVID-19 virus: interim guidance, 20 March 2020. Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/global-surveillance-for-covid-19-caused-by-human-infection-with-covid-19-virus-interim-guidance).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3